Dandan Jiang

553 total citations
29 papers, 449 citations indexed

About

Dandan Jiang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dandan Jiang has authored 29 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Dandan Jiang's work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (3 papers). Dandan Jiang is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (3 papers). Dandan Jiang collaborates with scholars based in China, Australia and Germany. Dandan Jiang's co-authors include Weiwei Mu, Yongjun Liu, Na Zhang, Shuang Liang, Funian Li, Kai‐Li Liu, Jingjing Yan, Fei Zhao, Shan Xiao and Shuhong Ye and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Dandan Jiang

29 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dandan Jiang China 13 240 102 98 78 63 29 449
Jingbo Yang China 15 310 1.3× 68 0.7× 101 1.0× 70 0.9× 80 1.3× 28 605
Tengteng Zou China 11 181 0.8× 145 1.4× 86 0.9× 151 1.9× 66 1.0× 11 470
Meng Lan China 12 210 0.9× 150 1.5× 93 0.9× 173 2.2× 67 1.1× 14 541
Lavinia Lupuţ Romania 13 203 0.8× 96 0.9× 91 0.9× 66 0.8× 89 1.4× 18 455
Peiliang Shen China 13 228 0.9× 62 0.6× 123 1.3× 69 0.9× 33 0.5× 23 485
Yuanhong Zheng China 13 235 1.0× 69 0.7× 108 1.1× 100 1.3× 140 2.2× 13 487
Vinod Balachandran India 12 315 1.3× 66 0.6× 38 0.4× 130 1.7× 62 1.0× 14 598

Countries citing papers authored by Dandan Jiang

Since Specialization
Citations

This map shows the geographic impact of Dandan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Jiang more than expected).

Fields of papers citing papers by Dandan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dandan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Jiang. The network helps show where Dandan Jiang may publish in the future.

Co-authorship network of co-authors of Dandan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Dandan Jiang. A scholar is included among the top collaborators of Dandan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dandan Jiang. Dandan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Dandan, Ziang Wang, Huimin Shen, et al.. (2024). Developing oxaliplatin and IL-15 Co-carried gels as drug depots to enable triple-interlocked combination therapy for colorectal cancer. Colloids and Surfaces B Biointerfaces. 241. 113996–113996. 2 indexed citations
2.
Liu, Mingzhou, et al.. (2023). GPD1 inhibits the carcinogenesis of breast cancer through increasing PI3K/AKT-mediated lipid metabolism signaling pathway. Heliyon. 9(7). e18128–e18128. 4 indexed citations
3.
Jiang, Dandan, Wolfgang Liebl, Maofeng Wang, et al.. (2023). Confirmation of Glucose Transporters through Targeted Mutagenesis and Transcriptional Analysis in Clostridium acetobutylicum. Fermentation. 9(1). 64–64. 1 indexed citations
4.
Zheng, Min, Shao Wang, Xiaoli Zhu, et al.. (2023). Duck cGAS inhibits DNA and RNA virus replication by activating IFNs and antiviral ISGs. Frontiers in Immunology. 14. 1101335–1101335. 1 indexed citations
5.
Liang, Shuang, Meichen Liu, Weiwei Mu, et al.. (2023). Nano‐Regulator Inhibits Tumor Immune Escape via the “Two‐Way Regulation” Epigenetic Therapy Strategy. Advanced Science. 11(9). e2305275–e2305275. 11 indexed citations
6.
Liang, Rui, Xinnan Liu, Jieqiong Chen, et al.. (2022). Neobavaisoflavone inhibits allergic inflammatory responses by suppressing mast cell activation. International Immunopharmacology. 110. 108953–108953. 6 indexed citations
7.
Liu, Yang, Shuang Liang, Dandan Jiang, et al.. (2021). Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies. Journal of Controlled Release. 336. 621–634. 32 indexed citations
8.
Jiang, Dandan, Tong Gao, Shuang Liang, et al.. (2021). Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy. ACS Applied Materials & Interfaces. 13(19). 22213–22224. 25 indexed citations
9.
Liu, Kai‐Li, et al.. (2020). Hispidulin: A promising flavonoid with diverse anti-cancer properties. Life Sciences. 259. 118395–118395. 53 indexed citations
10.
Wei, Feifei, et al.. (2020). Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR‐422a/PDK2 axis. Cancer Medicine. 9(7). 2480–2490. 24 indexed citations
11.
Jiang, Danni, et al.. (2018). Value of rapid on-site evaluation for ultrasound-guided thyroid fine needle aspiration. Journal of International Medical Research. 47(2). 626–634. 23 indexed citations
12.
Jiang, Dandan, Yuhua Song, Weihong Cao, et al.. (2018). p53‑independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells. Oncology Letters. 17(1). 1071–1079. 7 indexed citations
13.
Cheng, Shasha, Haitao Li, Dandan Jiang, et al.. (2016). Sensitive detection of trimethylamine based on dopant-assisted positive photoionization ion mobility spectrometry. Talanta. 162. 398–402. 19 indexed citations
14.
Zhang, Hao, et al.. (2015). Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells. Oncology Reports. 33(6). 3015–3023. 18 indexed citations
15.
Jiang, Dandan, et al.. (2015). [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].. PubMed. 95(30). 2474–7. 4 indexed citations
16.
Wang, Han, Dandan Jiang, Jing Liu, et al.. (2013). Compound K Induces Apoptosis of Bladder Cancer T24 Cells Via Reactive Oxygen Species-Mediated p38 MAPK Pathway. Cancer Biotherapy and Radiopharmaceuticals. 28(8). 607–614. 44 indexed citations
17.
Jiang, Dandan, Xingang Wang, Xiangping Liu, & Funian Li. (2013). Gene delivery of cyclin-dependent kinase inhibitors p21 Waf1 and p27 Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro. Breast Cancer. 21(5). 614–623. 15 indexed citations
18.
Wang, Han, Shuhong Ye, Shan Xiao, et al.. (2012). Beta-eleostearic acid induce apoptosis in T24 human bladder cancer cells through reactive oxygen species (ROS)-mediated pathway. Prostaglandins & Other Lipid Mediators. 99(1-2). 1–8. 14 indexed citations
19.
Jiang, Dandan, et al.. (2012). Clinicopathological significance of PTPN12 expression in human breast cancer. Brazilian Journal of Medical and Biological Research. 45(12). 1334–1340. 13 indexed citations
20.
Zhong, Like, et al.. (1999). [Effects of Ganoderma lucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells].. PubMed. 24(6). 521–4. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026